Literature DB >> 33081547

Bacterial death from treatment with fluoroquinolones and other lethal stressors.

Karl Drlica1, Xilin Zhao1,2.   

Abstract

INTRODUCTION: Lethal stressors, including antimicrobials, kill bacteria in part through a metabolic response proposed to involve reactive oxygen species (ROS). The quinolone anti-bacterials have served as key experimental tools in developing this idea. AREAS COVERED: Bacteriostatic and bactericidal action of quinolones are distinguished, with emphasis on the contribution of chromosome fragmentation and ROS accumulation to bacterial death. Action of non-quinolone antibacterials and non-antimicrobial stressors is described to provide a general framework for understanding stress-mediated, bacterial death. EXPERT OPINION: Quinolones trap topoisomerases on DNA in reversible complexes that block DNA replication and bacterial growth. At elevated drug concentrations, DNA ends are released from topoisomerase-mediated constraint, leading to the idea that death arises from chromosome fragmentation. However, DNA ends also stimulate repair, which is energetically expensive. An incompletely understood metabolic shift occurs, and ROS accumulate. Even after quinolone removal, ROS continue to amplify, generating secondary and tertiary damage that overwhelms repair and causes death. Repair may also contribute to death directly via DNA breaks arising from incomplete base-excision repair of ROS-oxidized nucleotides. Remarkably, perturbations that interfere with ROS accumulation confer tolerance to many diverse lethal agents.

Entities:  

Keywords:  Fluoroquinolones; antibiotics; bacterial death; lethal stress; reactive oxygen species

Year:  2020        PMID: 33081547     DOI: 10.1080/14787210.2021.1840353

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  7 in total

1.  Moxifloxacin-Mediated Killing of Mycobacterium tuberculosis Involves Respiratory Downshift, Reductive Stress, and Accumulation of Reactive Oxygen Species.

Authors:  Somnath Shee; Samsher Singh; Ashutosh Tripathi; Chandrani Thakur; Anand Kumar T; Mayashree Das; Vikas Yadav; Sakshi Kohli; Raju S Rajmani; Nagasuma Chandra; Harinath Chakrapani; Karl Drlica; Amit Singh
Journal:  Antimicrob Agents Chemother       Date:  2022-08-17       Impact factor: 5.938

2.  A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade.

Authors:  Jie Zeng; Yuzhi Hong; Ningqiu Zhao; Qianyu Liu; Weiwei Zhu; Lisheng Xiao; Weijie Wang; Miaomiao Chen; Shouqiang Hong; Liwen Wu; Yunxin Xue; Dai Wang; Jianjun Niu; Karl Drlica; Xilin Zhao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-01       Impact factor: 12.779

Review 3.  Oxygen and Metabolism: Digesting Determinants of Antibiotic Susceptibility in the Gut.

Authors:  Lauren R Heinzinger; Angus Johnson; Jenna I Wurster; Rachael Nilson; Swathi Penumutchu; Peter Belenky
Journal:  iScience       Date:  2020-11-30

4.  Dual Effect: High NADH Levels Contribute to Efflux-Mediated Antibiotic Resistance but Drive Lethality Mediated by Reactive Oxygen Species.

Authors:  Alejandro Arce-Rodríguez; Debbie Pankratz; Matthias Preusse; Pablo I Nikel; Susanne Häussler
Journal:  mBio       Date:  2022-01-18       Impact factor: 7.867

Review 5.  Fluoroquinolone heteroresistance, antimicrobial tolerance, and lethality enhancement.

Authors:  Amit Singh; Xilin Zhao; Karl Drlica
Journal:  Front Cell Infect Microbiol       Date:  2022-09-29       Impact factor: 6.073

Review 6.  Antimicrobials Functioning through ROS-Mediated Mechanisms: Current Insights.

Authors:  Ankita Vaishampayan; Elisabeth Grohmann
Journal:  Microorganisms       Date:  2021-12-28

7.  Effect of RecA inactivation and detoxification systems on the evolution of ciprofloxacin resistance in Escherichia coli.

Authors:  S Diaz-Diaz; E Recacha; A García-Duque; F Docobo-Pérez; J Blázquez; A Pascual; J M Rodríguez-Martínez
Journal:  J Antimicrob Chemother       Date:  2022-02-23       Impact factor: 5.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.